Working… Menu

Expanded Program for Immunization, a Missed Opportunity for Postpartum Family Planning Utilization

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04780243
Recruitment Status : Active, not recruiting
First Posted : March 3, 2021
Last Update Posted : March 3, 2021
Information provided by (Responsible Party):
Abebaw Abeje Muluneh, Hawassa University

Brief Summary:
This study is aimed to enhance postpartum family planning by integrating family planning information with infant immunization services, which is the most widely utilized health services globally.

Condition or disease Intervention/treatment Phase
Contraceptive Usage Other: counseling Not Applicable

Detailed Description:

In this study, a before-and-after type of quasi-experimental study will be conducted in purposely selected health centers Sidama region, Ethiopia. base line assessment of postpartum contraceptive utilization rate will be done which will be followed by an intervention. The intervention consists of screening, counseling for family planning and referring mothers coming for infant immunization services to family planning units. All mothers coming for infant immunization service will be screened for and counseled for family planning and those who will be voluntary to take any method will be referred to family planning unit. All mothers who will not be voluntary will be re-counseled by the next visit.

Finally, the effect of this intervention on postpartum contraceptive utilization rate will be reassessed. The expected outcome will be to see an improved contraceptive uptake during the first year after delivery.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 1474 participants
Allocation: Non-Randomized
Intervention Model: Sequential Assignment
Masking: Double (Participant, Care Provider)
Primary Purpose: Prevention
Official Title: Enhancing Postpartum Family Planning Utilization Through Integration With Expanded Program for Immunization in Sidama, South Ethiopia: A Quasi Experimental Study
Actual Study Start Date : February 1, 2020
Actual Primary Completion Date : August 30, 2020
Estimated Study Completion Date : March 17, 2021

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
No Intervention: Pre-intervention group
Pre-intervention group: women participated during the base line assessment will be labeled as Pre-intervention group
Experimental: postintervention group
Postintervention group: women participated after the intervention was initiated will be labeled as postintervention group.
Other: counseling
Mothers presented to infant immunization units are going to be counseled for family planning services and if decide to take any method, they will be linked to family planning services

Primary Outcome Measures :
  1. After the initiation of the intervention, improved Contraceptive prevalence rate will be expected as an outcome [ Time Frame: the outcome is measured two months after the initiation of the intervention ]
    After counseling of the postpartum mothers for family planning, their informed decision making capacity to use contraceptives will be increased.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • all women visiting health facilities for infant immunization for at least two times will be included.

Exclusion Criteria:

  • Women who are in difficulty of communicating during the study period will be excluded.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT04780243

Layout table for location information
Sidama regional health bureau
Hawassa, Sidama, Ethiopia
Sponsors and Collaborators
Hawassa University
Layout table for investigator information
Principal Investigator: Abebaw Muluneh Hawassa University
Layout table for additonal information
Responsible Party: Abebaw Abeje Muluneh, Mr., Hawassa University Identifier: NCT04780243    
Other Study ID Numbers: abe16muluneh
First Posted: March 3, 2021    Key Record Dates
Last Update Posted: March 3, 2021
Last Verified: March 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No